Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022430
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:42
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20025493x2_def14a.htm DEF 14A 1944933
2 logo_adc2.jpg GRAPHIC 47456
3 ny20025493x2_pc01.jpg GRAPHIC 510643
4 ny20025493x2_pc02.jpg GRAPHIC 1632118
  Complete submission text file 0001140361-24-022430.txt   4961639
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39071 | Film No.: 24883568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)